| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $811K | -9.2% | +21.7% |
| Cost of Revenue | $135K | -7.6% | +39.6% |
| Gross Profit | $676K | -9.6% | +18.7% |
| R&D Expense | $131K | +124.4% | +80.7% |
| SG&A Expense | $1.9M | -16.9% | -8.3% |
| Operating Income | -$2.1M | -22.3% | -27.2% |
| Interest Expense | $30K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.4M | -26.9% | +1577.8% |
| Accounts Receivable | $109K | -15.6% | +106.3% |
| Inventory | $110K | -16.1% | +390.9% |
| Current Assets | $5.0M | -24.6% | +689.4% |
| Total Assets | $5.8M | -18.5% | +405.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.5M | — | — |
| Capital Expenditures | $25K | — | — |
| Investing Cash Flow | $0 | +100.0% | +100.0% |
| Financing Cash Flow | $5.2M | — | — |
| Free Cash Flow | -$4.5M | — | — |
| +120.8% |
| -54.1% |
| Net Income | -$2.1M | -25.6% | -20.9% |
| EPS (Basic) | -$0.24 | -9.1% | +4.0% |
| EPS (Diluted) | -$0.24 | -9.1% | +4.0% |
| $3.1M |
| +34.1% |
| +18.1% |
| Total Liabilities | $3.5M | +23.2% | +18.9% |
| Stockholders' Equity | $2.3M | -46.3% | +227.4% |